A current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus

• Main Author: E V Biriukova
• Format: Article
• Language: Russian
• Published: "Consilium Medicum" Publishing house 2012-10-01
• Series: Терапевтический архив
• Subjects: type 2 diabetes mellitus; advance trial; cardiovascular risk prediction scale; sugar-lowering therapy
• Online Access: https://ter-arkhiv.ru/0040-3660/article/view/31160

Type 2 diabetes mellitus (T2DM) is a severe progressive disease complicating the development of micro- and macrovascular complications that result in early disability, including that in able-bodied persons, a reduction in the patients' life, and its worse quality. The author discusses the new scale developed according to the results of the ADVANCE trial for predicting the cardiovascular risk in patients with T2DM which may be used widely in these patients to estimate the risk of cardiovascular events and as a tool to assist in determining the intensity of treatment. She considers current approaches to treating T2DM, by using the results of the ADVANCE trial.